FDA NDC Directory · JSON-LD · Markdown

Sodium Polystyrene Sulfonate

NDC 17856-0024 · HUMAN PRESCRIPTION DRUG · POWDER, FOR SUSPENSION

Labeler / ManufacturerATLANTIC BIOLOGICALS CORP.
Marketing categoryAbbreviated NDA (generic) · App ANDA202333
Dosage form / routePOWDER, FOR SUSPENSION · ORAL
Active ingredientsSODIUM POLYSTYRENE SULFONATE (4.1 meq/g)
Marketing started20140414
Package count2

External sources

Source: openFDA. Public-domain (CC0).